PADAM BHATIA: Open Payments
NPI 1467746198 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$539 in 22 payments from 11 companies in 2025. Trend: 2023 $1,697 · 2024 $1,273 · 2025 $539
Food & beverage: $539
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 5 | $162 |
| Janssen Pharmaceuticals, Inc | 2 | $67 |
| ABBVIE INC. | 3 | $59 |
| Corium, LLC | 3 | $53 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
| Supernus Pharmaceuticals, Inc. | 2 | $39 |
| Vanda Pharmaceuticals Inc. | 1 | $29 |
| E.R. Squibb & Sons, L.L.C. | 1 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
Products named: Auvelity, SPRAVATO, VRAYLAR, Azstarys, REXULTI, Qelbree, FANAPT, COBENFY.
Industry payments across FL — which companies pay providers there.
